S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary

Editas Medicine (EDIT) Earnings Date, Estimates & Call Transcripts

$10.90
-0.21 (-1.89%)
(As of 12/7/2023 ET)
Compare
Today's Range
$10.77
▼
$11.20
50-Day Range
$6.25
▼
$11.11
52-Week Range
$6.08
▼
$11.93
Volume
1.65 million shs
Average Volume
1.81 million shs
Market Capitalization
$890.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.92
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Feb. 28Estimated
Actual EPS
(Nov. 3)
-$0.55 Beat By $0.09
Consensus EPS
(Nov. 3)
-$0.64
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

EDIT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EDIT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Editas Medicine Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.62)($0.62)($0.62)
Q2 20231($0.52)($0.52)($0.52)
Q3 20233($0.85)($0.51)($0.66)
Q4 20233($0.90)($0.44)($0.61)
FY 20238($2.89)($2.09)($2.41)
Q1 20241($0.84)($0.84)($0.84)
Q2 20241($0.86)($0.86)($0.86)
Q3 20241($0.93)($0.93)($0.93)
Q4 20241($0.90)($0.90)($0.90)
FY 20244($3.53)($3.53)($3.53)
Q1 20251($0.89)($0.89)($0.89)
Q2 20251($0.88)($0.88)($0.88)
Q3 20251($0.88)($0.88)($0.88)

EDIT Earnings Date and Information

Editas Medicine last issued its earnings results on November 3rd, 2023. The reported ($0.55) EPS for the quarter, beating analysts' consensus estimates of ($0.64) by $0.09. The business had revenue of $5.34 million for the quarter, compared to analysts' expectations of $3.70 million. Its revenue for the quarter was up 1171.4% compared to the same quarter last year. Editas Medicine has generated ($2.70) earnings per share over the last year (($2.70) diluted earnings per share). Earnings for Editas Medicine are expected to decrease in the coming year, from ($2.40) to ($2.55) per share. Editas Medicine has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 28th, 2024 based off prior year's report dates.

Editas Medicine Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/28/2024
Estimated)		------- 
11/3/2023Q3 2023($0.64)($0.55)+$0.09($0.55)$3.70 million$5.34 million    
8/2/2023Q2 2023($0.76)($0.56)+$0.20($0.56)$4.17 million$2.89 million  
5/5/2023Q1 2023($0.79)($0.71)+$0.08($0.71)$3.29 million$9.90 million    
2/22/2023Q4 2022($0.84)($0.88)($0.04)($0.88)$3.76 million$6.54 million    
11/2/2022Q3 2022($0.87)($0.81)+$0.06($0.81)$5.86 million$0.04 million    
8/3/2022Q2 2022($0.84)($0.78)+$0.06($0.78)$4.29 million$6.36 million    
5/4/2022Q1 2022($0.81)($0.74)+$0.07($0.74)$3.85 million$6.80 million    
2/24/2022Q4 2021($0.78)($0.61)+$0.17($0.61)$4.70 million$12.50 million    
11/8/2021Q3 2021($0.81)($0.57)+$0.24($0.57)$4.92 million$6.20 million    
8/4/2021Q2 2021($0.85)($0.81)+$0.04($0.81)$6.78 million$0.38 million    
5/5/2021Q1 2021($0.76)($0.86)($0.10)($0.86)$5.78 million$6.50 million  
2/25/2021Q4 2020($0.81)($1.00)($0.19)($1.00)$5.64 million$11.42 million  












Editas Medicine Earnings - Frequently Asked Questions

When is Editas Medicine's earnings date?

Editas Medicine has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 28th, 2024 based off last year's report dates. Learn more on EDIT's earnings history.

Did Editas Medicine beat their earnings estimates last quarter?

In the previous quarter, Editas Medicine (NASDAQ:EDIT) reported ($0.55) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.64) by $0.09. Learn more on analysts' earnings estimate vs. EDIT's actual earnings.

How can I listen to Editas Medicine's earnings conference call?

The conference call for Editas Medicine's latest earnings report can be listened to online. Listen to Conference Call

How can I read Editas Medicine's conference call transcript?

The conference call transcript for Editas Medicine's latest earnings report can be read online. Read Transcript

How much revenue does Editas Medicine generate each year?

Editas Medicine (NASDAQ:EDIT) has a recorded annual revenue of $24.61 million.

How much profit does Editas Medicine generate each year?

Editas Medicine (NASDAQ:EDIT) has a recorded net income of -$220.43 million. EDIT has generated -$2.70 earnings per share over the last four quarters.

What is Editas Medicine's EPS forecast for next year?

Editas Medicine's earnings are expected to decrease from ($2.40) per share to ($2.55) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:EDIT) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -